Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for SRx Health Solutions (SRXH) over the last 10 years, with Q2 2025 value amounting to 235.21%.

  • SRx Health Solutions' EBITDA Margin fell 2487700.0% to 235.21% in Q2 2025 from the same period last year, while for Jun 2025 it was 41.95%, marking a year-over-year decrease of 246300.0%. This contributed to the annual value of 32.73% for FY2024, which is 876100.0% up from last year.
  • As of Q2 2025, SRx Health Solutions' EBITDA Margin stood at 235.21%, which was down 2487700.0% from 15.2% recorded in Q1 2025.
  • In the past 5 years, SRx Health Solutions' EBITDA Margin registered a high of 44.33% during Q4 2024, and its lowest value of 260.71% during Q4 2022.
  • Over the past 5 years, SRx Health Solutions' median EBITDA Margin value was 29.57% (recorded in 2021), while the average stood at 58.45%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 2674700bps in 2024, then plummeted by -2487700bps in 2025.
  • SRx Health Solutions' EBITDA Margin (Quarter) stood at 45.3% in 2021, then crashed by -476bps to 260.71% in 2022, then increased by 14bps to 223.13% in 2023, then skyrocketed by 120bps to 44.33% in 2024, then plummeted by -631bps to 235.21% in 2025.
  • Its EBITDA Margin was 235.21% in Q2 2025, compared to 15.2% in Q1 2025 and 44.33% in Q4 2024.